Nishant K Mishra on Preventing Post-Stroke Seizures
Nishant K Mishra, Stroke Director at U.S. Department of Veterans Affairs, shared on LinkedIn:
”Delighted to share our thoughts on treatment and prevention strategies for post stroke epilepsy”
Stroke is the leading cause of new-onset seizures and epilepsy in older adults and is linked to higher morbidity and mortality.
Post-stroke seizures are classified as early or late, depending on whether they occur within or after 7 days of the stroke, with a single late seizure sufficient to diagnose post-stroke epilepsy.
This review outlines current strategies for diagnosing and managing post-stroke seizures, highlighting levetiracetam and lamotrigine as potentially preferred options for reducing acute seizure recurrence despite limited evidence.
It also emphasizes the lack of data on several other agents and suggests that future research, particularly into biomarkers of epileptogenesis, could enable more practical and informative clinical trials.
Read the full article here.
Article: Pharmacological strategies for preventing post-stroke seizures and epilepsy
Authors: Yuki Kawamura, Eugen Trinka, Terence J. Quinn, Hedley C. A. Emsley, Johan Zelano, Tomotaka Tanaka, Masafumi Ihara, Lauren H. Sansing, David S. Liebeskind, Nishant K Mishra
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors